Jiang Zhu

age ~52

from Hockessin, DE

Get Report

Also known as:

Jian G Zhu
Jing Zhu
Zhu J Jiang
Qi Jiang

Phone and address:: 3 Harvest Ln, Hockessin, DE 19707

Connected to:

Jiang Zhu Phones & Addresses

3 Harvest Ln, Hockessin, DE 19707
Ellicott City, MD
Newark, DE
Wilmington, DE
Rego Park, NY
Bear, DE
New Castle, DE
417 Harrison Dr, Hockessin, DE 19707

Isbn (Books And Publications)

Gua Sha Liao Fa

view source

Author
Jiang Zhu

ISBN #
7534529387

Name / Title

Company / Classification

Phones & Addresses

Jiang Zhu

EASY BOOKKEEPING SOLUTIONS, LLC

Jiang Zhu

INTERNATIONAL INFORMATION SERVICE, INC

Us Patents

Neutralizing Antibodies To Hiv-1 And Their Use
view source
US Patent:

20120237523, Sep 20, 2012
Filed:

Mar 23, 2012
Appl. No.:

13/429286
Inventors:

John R. Mascola - Rockville MD, US
Richard T. Wyatt - San Diego CA, US
Xueling Wu - Potomac MD, US
Yuxing Li - Boyds MD, US
Carl-Magnus Hogerkorp - Vellinge, SE
Mario Roederer - Washington DC, US
Zhi-yong Yang - Potomac MD, US
Gary J. Nabel - Washington DC, US
Peter D. Kwong - Washington DC, US
Tongqing Zhou - Boyds MD, US
Mark Connors - Bethesda MD, US
Gilad Ofek - Washington DC, US
Lawrence Shapiro - Bethesda MD, US
Jiang Zhu - Ashburn VA, US
William R. Schief - Encinitas CA, US
International Classification:

A61K 39/42
C12N 15/13
A61P 31/18
G01N 33/566
G01N 33/569
C12N 1/21
C12N 5/10
C12N 1/19
C07K 16/10
C12N 15/63
US Classification:

4241421, 53038815, 5303873, 5303913, 536 2353, 4353201, 435 5, 43525233, 43525231, 43525235, 43525234, 4353391, 4352542, 436501, 5303879
Abstract:

Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and the use of these antibodies are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes.

Neutralizing Antibodies To Hiv-1 And Their Use
view source
US Patent:

20120244166, Sep 27, 2012
Filed:

Mar 23, 2012
Appl. No.:

13/429279
Inventors:

John R. Mascola - Rockville MD, US
Richard T. Wyatt - San Diego CA, US
Xueling Wu - Potomac MD, US
Yuxing Li - Boyds MD, US
Carl-Magnus Hogerkorp - Vellinge, SE
Mario Roederer - Washington DC, US
Zhi-yong Yang - Potomac MD, US
Gary J. Nabel - Washington DC, US
Peter D. Kwong - Washington DC, US
Tongqing Zhou - Boyds MD, US
Mark Connors - Bethesda MD, US
Gilad Ofek - Washington DC, US
Lawrence Shapiro - Bethesda MD, US
Jiang Zhu - Ashburn VA, US
William R. Schief - Encinitas CA, US
International Classification:

A61K 39/395
C12N 15/63
C12N 1/21
C12N 1/19
A61P 31/18
C12N 15/74
G01N 21/64
C07K 16/10
C12N 15/13
C12N 9/96
C12N 5/10
US Classification:

4241421, 435188, 4353201, 43525233, 4352523, 43525235, 43525231, 4352542, 4353391, 435 5, 436501, 53038815, 5303873, 5303913, 536 2353
Abstract:

Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and uses of these antibodies, are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes.

Neutralizing Antibodies To Hiv-1 And Their Use
view source
US Patent:

20120282264, Nov 8, 2012
Filed:

Sep 24, 2010
Appl. No.:

13/498125
Inventors:

John R. Mascola - Rockville MD, US
Richard Wyatt - San Diego CA, US
Xueling Wu - Potomac MD, US
Yuxing Li - Boyds MD, US
Carl-Magnus Hogerkorp - Malmo, SE
Mario Roederer - Bethesda MD, US
Zhi-yong Yang - Potomac MD, US
Gary Nabel - Washington DC, US
Peter Kwong - Washington DC, US
Tongqing Zhou - Boyds MD, US
Mark Connors - Bethesda MD, US
Gilad Ofek - Washington DC, US
Lawrence Shapiro - Bethesda MD, US
Jiang Zhu - Bethesda MD, US
William R. Schief - Seattle WA, US
International Classification:

C07K 16/10
A61K 39/42
C12N 15/13
C12N 1/21
C12N 15/74
G01N 33/569
A61P 31/18
G01N 33/577
C12N 9/96
C12N 15/63
US Classification:

4241421, 53038815, 5303873, 5303913, 435188, 536 2353, 4353201, 5303894, 435 5, 436501, 43525231, 4352523, 43525235
Abstract:

Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and the use of these antibodies are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes.

Neutralizing Gp41 Antibodies And Their Use
view source
US Patent:

20180002406, Jan 4, 2018
Filed:

Sep 8, 2017
Appl. No.:

15/699902
Inventors:

- Bethesda MD, US
Jinghe Huang - Bethesda MD, US
Leo B. Laub - Richmond VA, US
Peter Kwong - Washington DC, US
Gary Nabel - Cambridge MA, US
John R. Mascola - Rockville MD, US
Baoshan Zhang - Bethesda MD, US
Rebecca S. Rudicell - Silver Springs MD, US
Ivelin Georgiev - Gaithersburg MD, US
Yongping Yang - Potomac MD, US
Jiang Zhu - Ashburn VA, US
Gilad Ofek - Washington DC, US
Assignee:

The United States of America, as represented by the Secretary, Department of Health and Human - Bethesda MD
International Classification:

C07K 16/10
A61K 45/06
C07K 16/00
A61K 39/42
G01N 33/569
A61K 49/00
A61K 39/00
Abstract:

Monoclonal neutralizing antibodies are disclosed that specifically bind to the HIV-1 gp41 membrane-proximal external region (MPER). Also disclosed are compositions including the disclosed antibodies that specifically bind gp41, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of HIV-1 in a biological sample, or detecting an HIV-1 infection or diagnosing AIDS in a subject. In additional, the broad neutralization breadth of the disclosed antibodies makes them ideal for treating a subject with an HIV infection. Thus, disclosed are methods of treating and/or preventing HIV infection.

Neutralizing Gp41 Antibodies And Their Use
view source
US Patent:

20160333076, Nov 17, 2016
Filed:

Aug 2, 2016
Appl. No.:

15/226744
Inventors:

- Bethesda MD, US
Jinghe Huang - Bethesda MD, US
Leo B. Laub - Richmond VA, US
Peter Kwong - Washington DC, US
Gary Nabel - Cambridge MA, US
John R. Mascola - Rockville MD, US
Baoshan Zhang - Bethesda MD, US
Rebecca S. Rudicell - Silver Springs MD, US
Ivelin Georgiev - Gaithersburg MD, US
Yongping Yang - Potomac MD, US
Jiang Zhu - Ashburn VA, US
Gilad Ofek - Washington DC, US
Assignee:

The United States of America, as represented by the Secretary, Department of Health and Human Serv - Bethesda MD
International Classification:

C07K 16/10
G01N 33/569
Abstract:

Monoclonal neutralizing antibodies are disclosed that specifically bind to the HIV-1 gp41 membrane-proximal external region (MPER). Also disclosed are compositions including the disclosed antibodies that specifically bind gp41, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of HIV-1 in a biological sample, or detecting an HIV-1 infection or diagnosing AIDS in a subject. In additional, the broad neutralization breadth of the disclosed antibodies makes them ideal for treating a subject with an HIV infection. Thus, disclosed are methods of treating and/or preventing HIV infection.

Neutralizing Gp41 Antibodies And Their Use
view source
US Patent:

20140348785, Nov 27, 2014
Filed:

Nov 7, 2012
Appl. No.:

14/356557
Inventors:

- Bethesda MD, US
Jinghe Huang - Bethesda MD, US
Leo B. Laub - Richmond VA, US
Peter Kwong - Washington DC, US
Gary Nabel - Cambridge MA, US
John R. Mascola - Rockville MD, US
Baoshan Zhang - Bethesda MD, US
Rebecca S. Rudicell - Silver Springs MD, US
Ivelin Georgiev - Gaithersburg MD, US
Yongping Yang - Potomac MD, US
Jiang Zhu - Ashburn VA, US
Gilad Ofek - Washington DC, US
International Classification:

C07K 16/10
G01N 33/569
A61K 45/06
A61K 49/00
A61K 39/42
US Classification:

424 852, 5303879, 5303873, 5303911, 5303913, 536 2353, 4241391, 514 44 R, 4353201, 435 5, 43525233, 4352523, 4352542, 435331, 43525231, 43525235, 43525234
Abstract:

Monoclonal neutralizing antibodies are disclosed that specifically bind to the HIV-1 gp41 membrane-proximal external region (MPER). Also disclosed are compositions including the disclosed antibodies that specifically bind gp41, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of HIV-1 in a biological sample, or detecting an HIV-1 infection or diagnosing AIDS in a subject. In additional, the broad neutralization breadth of the disclosed antibodies makes them ideal for treating a subject with an HIV infection. Thus, disclosed are methods of treating and/or preventing HIV infection.

Immunogens Based On An Hiv-1 V1V2 Site-Of-Vulnerability
view source
US Patent:

20140348865, Nov 27, 2014
Filed:

Sep 7, 2012
Appl. No.:

14/344589
Inventors:

- Bethesda MD, US
- Baltimore MD, US
- Seattle WA, US
Jason Gorman - Washington DC, US
Mallika Sastry - Rockville MD, US
Kaifan Dai - La Jolla CA, US
Tongqing Zhou - Boyds MD, US
John Mascola - Rockville MD, US
Gary Nabel - Cambridge MA, US
Masaru Kanekiyo - Chevy Chase MD, US
Yongping Yang - Potomac MD, US
Jiang Zhu - Ashburn VA, US
Lai-Xi Wang - Ellicott City MD, US
William Schief - Encinitas CA, US
Chris Carrico - San Francisco CA, US
Mohammed Amin - Baltimore MD, US
International Classification:

C07K 14/005
C12N 7/00
US Classification:

4241881, 530405, 536 2372, 4353201
Abstract:

Disclosed are HIV immunogens. Also disclosed are nucleic acids encoding these immunogens and methods of producing these antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject.

A Novel Process For The Preparation Of N-(4-Nitro-2-Sulfamoyl-Phenyl)-Malonamic Acid Methyl Ester And N-(4-Amino-2-Sulfamoyl-Phenyl)-Malonamic Acid Methyl Ester
view source
US Patent:

20140200362, Jul 17, 2014
Filed:

Jan 13, 2014
Appl. No.:

14/153878
Inventors:

- Nutley NJ, US
Jiang Zhu - Wayne NJ, US
Assignee:

Hoffmann-La Roche Inc. - Nutley NJ
International Classification:

C07C 303/40
US Classification:

560 13
Abstract:

The present invention provides a novel method for preparing compounds N-(4-nitro-2-sulfamoyl-phenyl)-malonamic acid methyl ester and N-(4-amino-2-sulfamoyl-phenyl)-malonamic acid methyl ester, which are novel intermediates for preparing a key intermediate N-(4-methanesulfonylamino-2-sulfamoyl-phenyl)-malonamic acid methyl ester, for the preparation of N-(3-{(1R,2S,7R,8S)-3-[(4-fluorophenyl)methyl]-6-hydroxy-4-oxo-3-azatricyclo [6.2.1.0]undec-5-en-5-yl}-1,1-dioxo-1,4-dihydro-1λ,2,4-benzothiadiazin-7-yl)methanesulfonamide, also known commercially as Setrobuvir, a compound useful in treating hepatitis C.

Resumes

Jiang Zhu

view source

Location:

United States

Jiang Zhu College Park, MD

view source

Work:

Smith Master Student Association

2014 to 2014
Ambassador HSBC
Wuhan, CN
2013 to 2013
Elite Program Intern China Guangfa Bank
Wuhan, CN
2013 to 2013
Personal Wealth Management Intern Youth Development and Service Center
Wuhan, CN
2012 to 2012
Deputy Director of Publicity Department

Education:

School of Information Management, Wuhan University
Wuhan, CN
2014
Dual in Information Management Robert H. Smith School of Business, University of Maryland
College Park, MD
Master of Finance

Jiang Zhu Hillsborough, NJ

view source

Work:

HONEYWELL INTERNATIONAL
Morristown, NJ
Jun 2011 to Mar 2012
Global Demand Planning Leader SYSCO GUEST SUPPLY INC
Monmouth Junction, NJ
May 2005 to May 2011
Inventory Systems Manager CARDINAL HEALTH, INC
Philadelphia, PA
May 2003 to May 2005
Warehouse & Manufacturing Project Lead

Education:

University of Delaware
Newark, DE
May 2000
MBA in Operations Management Institute of International Relations
Jul 1995
Bachelor of Arts in Law

Jiang Zhu

view source

Work:

InSysCo

Nov 2011 to Present
Configuration Manager IRS CADE project, CSC

Jan 2007 to Present
Team Lead, Development Environment and Tool Support (Contractor) Innovative Concepts Inc
McLean, VA
Sep 2006 to Mar 2007
Configuration Manager SCM
Clarksburg, MD
Mar 2004 to Sep 2006
Engineer/Build Specialist Sentito Networks Inc
Rockville, MD
Nov 2002 to Mar 2004
Software Configuration Manager ARMILLAIRE Technologies Inc
Bethesda, MD
Mar 2000 to Mar 2002
CM/QA Team Lead Comsat Labs
Clarksburg, MD
Feb 1998 to Feb 2000
Software Lead GE-Spacenet Services
McLean, VA
Oct 1996 to Feb 1998
Software Engineer Denro Inc
Gaithersburg, MD
Sep 1995 to Oct 1996
Senior Software Engineer Naval Research Laboratory
Washington, DC
May 1992 to Sep 1995
Electrical Engineer

Education:

George Washington University
Washington, DC
Dec 1995
MSEE University of Maryland
College Park, MD
Dec 1991
BSEE

Amazon

Night ten: This time. I just talk the truth(Chinese Edition)

view source

Paperback. Pub Date :2014-01-01 Pages: 288 Publisher: Hunan People's Publishing House Ao knowledge with his decades of experience. rich knowledge tells the reader what Freedom is. This time. I just talk the truth about the history. literature. stories. expand freedom. language sharp. informative. le...

Author
LI AO [ ZHU JIANG ]

Binding
Paperback

Pages
282

Publisher
Hunan People's Publishing House

ISBN #
7543898098

EAN Code
9787543898097

ISBN #
3

Chart of the Ear Reflective Zones (English and Chinese Edition)

view source

The colorful chart presents all ear zones reflecting different parts or organs of human body. Captioning in both Chinese and English, the chart is great as a teaching tool and reference. A 13-page booklet of description on the reflective zones and their functions in Chinese and a package of pressing...

Author
Jiang Zhu

Binding
Map

Pages
1

Publisher
Beijing Science & Technology Press,China

ISBN #
7530428578

EAN Code
9787530428573

ISBN #
1

Partial Ordering Methods In Nonlinear Problems

view source

Book by Guo, Dajun, Cho, Yeol Je, Zhu, Jiang

Author
Dajun Guo, Yeol Je Cho, Jiang Zhu

Binding
Hardcover

Pages
344

Publisher
Nova Science Pub Inc

ISBN #
1594540187

EAN Code
9781594540189

ISBN #
4

NTCs Dictionary of Everyday American English Expressions (Chinese Edition)

view source

Author
mei si pi er si deng zhu zhang jiang xu zhong yi

Binding
Paperback

Pages
409

Publisher
Shanghai Translation Publishing House

ISBN #
7532726304

EAN Code
9787532726301

ISBN #
10

Youtube

Ming Jiang Zhu 909 vs Lazzaro Zucchi Violin

This is a comparison between the Ming Jiang Zhu 909 and the Lazzaro Zu...

Duration:

1m 20s

Ming Jiang Zhu Violin Comparison Playthrough

These are all of the models by Ming Jiang Zhu that we currently carry ...

Duration:

5m 24s

Ming Jiang Zhu Violin Review - Schindler's List

Zhu Ming-Jiang is the Chinese who has won the greatest number and high...

Duration:

5m 26s

Cargnelutti, Ming Jiang Zhu 925, Anedda Violi...

This video is for our dear customer Tim, but for everyone else, you ca...

Duration:

9m 19s

Three Ming Jiang Zhu 909 Violins (with "Schin...

This video is for our dear customer Terri, but for everyone else, you ...

Duration:

8m

Ming Jiang Zhu 905 Violin review

Ming Jiang Zhu 905 Violin playing Bach. Check out the 905 on our websi...

Duration:

36s

Myspace

jiang zhu

view source

Locality:

New South Wales, Australia

Gender:

Male

Birthday:

1948

Facebook

Jiang Zhu

view source

Jiang Zhu

view source

(Jiang Zhu)

view source

Shao Zhu Jiang

view source

Jiang Shi Zhu

view source

Jiang Zhu Azang Ventura

view source

Jiang Zhu

view source

Jiang Zhu

view source

News

Study of ancient climate suggests future warming could accelerate

view source

"We were surprised that the climate sensitivity increased as much as it did with increasing carbon dioxide levels," said first author Jiang Zhu, a postdoctoral researcher at the U-M Department of Earth and Environmental Sciences.
Date: Sep 18, 2019
Category: Science
Source: Google

HIV Vaccine Awareness Day: Research continues for effective preventive, therapeutic vaccines

view source

This is actually the first example of how we can go back to the really early stage to see how this particular antibody lineage was born and can develop, TSRI researcher and biologist Jiang Zhu, PhD, said in a press release. Read more.
Date: May 18, 2016
Category: Health
Source: Google